Medicine shortage reports database

The medicine shortage reports database includes information about shortages of reportable medicines in Australia, including those arising from the discontinuation of products.

You can use this page to search for all medicines in shortage and find information about management actions, including supply of overseas alternative medicines.

Information in this database is based on details reported to us by sponsors. Any additional management actions taken by us will be clearly stated.

How to search

The database defaults to all current medicine shortages. You can also view anticipated and resolved shortages and discontinuations.

To search the database for all shortages and discontinuations for a particular medicine, type the active ingredient or trade (brand) name into the search field. You can then click on the active ingredient name or trade name for more information about the shortage of interest.

You can also download an extract of all shortages and discontinuations.

To view all medicines shortages and discontinuations with a critical shortage impact rating, click on the CRITICAL medicine shortages link below.

Further information

Information about medicine shortages is available at the Medicine Shortages hub

Subscribe to Medicine Shortages updates

You can subscribe to Medicine Shortages Email Alerts or the Medicine Shortages RSS feed for frequently updated information.


This service does not support Internet Explorer 7 and below.

Browse CRITICAL shortages and discontinuations

Click here to display ALL medicine shortages and discontinuations

fytic acid

calcium chloride dihydrate

potassium hydrogen phthalate

RADPHARM COLLOID kit for the preparation of Technetium(99mTc) calcium phytate injection composite pack

AUST R: 14332

Expected supply: 31 May 2023

Availability: Unavailable

Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.

Updated: 24-05-2022


phenoxybenzamine hydrochloride

DIBENYLINE phenoxybenzamine hydrochloride 10mg capsule jar

AUST R: 12980

Expected supply: 30 Jun 2023

Availability: Unavailable

Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient..

Updated: 20-06-2022


dantrolene sodium hemiheptahydrate

DANTRIUM dantrolene sodium hemiheptahydrate 25mg capsule bottle

AUST R: 42975

Expected supply: 31 Dec 2023

Availability: Unavailable

Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.

Updated: 17-06-2022


dantrolene sodium hemiheptahydrate

DANTRIUM dantrolene sodium hemiheptahydrate 50mg capsule bottle

AUST R: 42976

Expected supply: 31 Dec 2023

Availability: Unavailable

Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.

Updated: 26-07-2022


fomepizole

ANTIZOL fomepizole 1.5g/1.5mL concentrated injection vial

AUST R: 263913

Expected supply: 30 Sep 2022

Availability: Unavailable

Management action: Stock is available from the sponsor to supply via the Special Access Scheme

Updated: 22-06-2022


Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain)

ONCOTICE BCG 5 hundred million CFU powder for injection vial

AUST R: 59912

Expected supply: 31 Dec 2024

Availability: Limited Availability

Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient

Updated: 07-03-2022


bleomycin sulfate

CIPLA BLEOMYCIN 15K bleomycin sulfate 15000 IU powder for injection vial

AUST R: 220440

Expected supply: 30 Jun 2021

Availability: Unavailable

Management action: Alternative brands are available.

Updated: 16-06-2022


amifostine

ETHYOL Amifostine (as trihydrate) 500mg powder for injection vial

AUST R: 63789

Expected supply: 31 Jul 2023

Availability: Unavailable

Management action: Alternative unapproved products available under the Special Access Scheme.

Updated: 27-07-2022


sulfamethoxazole

trimethoprim

DBL SULFAMETHOXAZOLE 400 mg AND TRIMETHOPRIM 80 mg CONCENTRATE INJECTION BP 5mL injection ampoule

AUST R: 16293

Expected supply: 24 Feb 2023

Availability: Unavailable

Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient

Updated: 11-07-2022


iobenguane (123I) sulfate

MIBGEN iobenguane[123I] sulfate 100MBq/mL injection vial

AUST R: 101670

Expected supply: 31 Dec 2022

Availability: Unavailable

Management action: Alternative unapproved products available under the Special Access Scheme (SAS). For further information about the SAS scheme please see https://www.tga.gov.au/form/special-access-scheme

Updated: 16-12-2021


tetracosactide (tetracosactrin)

SYNACTHEN DEPOT tetracosactide (tetracosactrin) zinc complex 1mg/1m L injection ampoule

AUST R: 11060

Expected supply: 30 Nov 2022

Availability: Unavailable

Management action: Alternative unapproved products available under the Special Access Scheme (SAS). For further information about the SAS scheme please see https://www.tga.gov.au/form/special-access-scheme

Updated: 16-06-2022


gentamicin sulfate

DBL GENTAMICIN 10mg/1mL (as sulfate) injection ampoule

AUST R: 16339

Expected supply: Unknown

Availability: Unavailable

Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient

Updated: 30-03-2022


procaine benzylpenicillin (procaine penicillin)

CILICAINE SYRINGE 1.5 procaine benzylpenicillin (procaine penicillin) 1.5g injection syringe

AUST R: 288818

Expected supply: 31 Aug 2022

Availability: Unavailable

Management action: Sponsor is working to expedite the next shipment.

Updated: 27-07-2022


flucytosine

ANCOTIL flucytosine 2.5g/250mL injection bottle

AUST R: 13705

Expected supply: Unknown

Availability: Reduction in supply until supply is exhausted

Management action: Alternative unapproved products may be available under the Special Access Scheme (SAS). For further information about the SAS scheme please see https://www.tga.gov.au/form/special-access-scheme

Updated: 16-06-2022


hydralazine hydrochloride

HYDRALAZINE LINK hydralazine hydrochloride 20 mg/1 mL solution for injection vial

AUST R: 272644

Expected supply: 31 Jan 2023

Availability: Unavailable

Management action: Alternative generic products may be available

Updated: 16-06-2022


voriconazole

VORCON voriconazole 200 mg powder for injection vial

AUST R: 235933

Expected supply: 31 Dec 2022

Availability: Unavailable

Management action: Alternative generic products are available.

Updated: 14-06-2022


voriconazole

ZOLFEND voriconazole 200 mg powder for injection vial

AUST R: 238265

Expected supply: Unknown

Availability: Available

Management action: Alternative generic products are available.

Updated: 14-06-2022


activated charcoal

sorbitol

CARBOSORB XS activated charcoal 50 g/250 mL and sorbitol 70.75 g/250 mL suspension bottle

AUST R: 307429

Expected supply: 01 Nov 2022

Availability: Unavailable

Management action: Possible therapeutic alternative available.
CARBOSORB X activated charcoal 50 g/250 mL suspension bottle ARTG ID: 106470

Updated: 14-06-2022


human chorionic gonadotrophin

PREGNYL gonadotrophin - chorionic human 1500IU powder for injection vial with diluent vial

AUST R: 273873

Expected supply: Unknown

Availability: Unavailable

Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
The sponsor of this s19A product, Medsurge can be contacted on: 1300 788 261 for details on supply.

Updated: 11-10-2021


human chorionic gonadotrophin

PREGNYL gonadotrophin - chorionic human 5000IU powder for injection vial with diluent vial

AUST R: 273874

Expected supply: Unknown

Availability: Unavailable

Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
The sponsor of this s19A product, Organon Pharma can be contacted on: 1800 023 135 for details on supply.

Updated: 11-10-2021


dexamethasone sodium phosphate

DBL DEXAMETHASONE SODIUM PHOSPHATE INJECTION 4mg/1mL (as sodium) injection ampoule

AUST R: 16374

Expected supply: Unknown

Availability: Unavailable

Management action: An alternate presentation of the same strength is available.

Updated: 06-04-2022


ciprofloxacin

DBL CIPROFLOXACIN 400 mg/200 mL injection for intravenous infusion bag

AUST R: 123042

Expected supply: 13 May 2022

Availability: Available

Updated: 18-05-2022


adrenaline (epinephrine) acid tartrate

lidocaine (lignocaine) hydrochloride

XYLOCAINE 1% WITH ADRENALINE 1:200,000 20mL injection vial

AUST R: 12015

Expected supply: 15 Sep 2022

Availability: Unavailable

Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.

Updated: 10-02-2022


adrenaline (epinephrine) acid tartrate

lidocaine (lignocaine) hydrochloride

XYLOCAINE 2% WITH ADRENALINE 1:200,000 20mL injection vial

AUST R: 12021

Expected supply: 15 Sep 2022

Availability: Unavailable

Management action: Unregistered products have been approved for supply under Section 19A to Medsurge Healthcare Pty Ltd (1300 788 261) and Pro Pharmaceuticals Group Pty Ltd (1300 077 674).

Updated: 31-01-2022


adrenaline (epinephrine) acid tartrate

lidocaine (lignocaine) hydrochloride

XYLOCAINE 0.5% WITH ADRENALINE 1:200,000 20mL injection vial

AUST R: 12008

Expected supply: 15 Sep 2022

Availability: Unavailable

Management action: An unregistered product in other strength has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.

Updated: 14-06-2022


nivolumab

OPDIVO nivolumab 40 mg in 4 mL (10 mg/mL) concentrated solution for IV infusion vial

AUST R: 231867

Expected supply: 24 May 2022

Availability: Available

Updated: 24-05-2022


rifampicin

RIMYCIN 300 rifampicin 300 mg capsule bottle

AUST R: 48231

Expected supply: 31 Aug 2022

Availability: Limited Availability

Management action: Alternative generic products are available.

Updated: 16-06-2022


calcium folinate

DBL LEUCOVORIN CALCIUM folinic acid 50 mg/5 mL (as calcium folinate) injection USP vial (NF)

AUST R: 42148

Expected supply: 19 Aug 2022

Availability: Limited Availability

Updated: 03-08-2022


imipramine hydrochloride

TOFRANIL 25 imipramine hydrochloride 25mg tablet blister pack

AUST R: 60673

Expected supply: 31 Oct 2022

Availability: Unavailable

Management action: An unregistered product has been approved for supply under Section 19A. The approval holder, Pro Pharmaceuticals Group can be contacted on 1300 077 674 for details on supply.

Updated: 18-05-2022


hydrochlorothiazide

quinapril hydrochloride

ACCURETIC 10/12.5 tablet blister pack

AUST R: 81930

Expected supply: 30 Apr 2023

Availability: Unavailable

Updated: 03-05-2022


hydrochlorothiazide

quinapril hydrochloride

ACCURETIC 20/12.5 tablet blister pack

AUST R: 81931

Expected supply: 30 Apr 2023

Availability: Unavailable

Updated: 03-05-2022


Funnelweb spider antivenom

FUNNEL WEB SPIDER ANTIVENOM (RABBIT) 125U powder for injection vial

AUST R: 31847

Expected supply: 31 Jan 2023

Availability: Available

Management action: The sponsor is closely controlling the supply.

Updated: 02-07-2022


dexamethasone sodium phosphate

DEXAMETHASONE MYLAN dexamethasone phosphate (as dexamethasone sodium phosphate) 4mg/1mL solution for injection vial

AUST R: 163200

Expected supply: 27 Oct 2022

Availability: Limited Availability

Management action: An unregistered product has been approved for supply under Section 19A. The approval holder, Alphapharm Pty Ltd can be contacted on 1800 274 276 for details on supply

Updated: 12-07-2022


vancomycin hydrochloride

VANCOMYCIN JUNO vancomycin (as hydrochloride) 1 g powder for injection vial

AUST R: 330502

Expected supply: 25 Jul 2022

Availability: Available

Updated: 26-07-2022


benzylpenicillin sodium

BENPEN benzylpenicillin (as sodium) 3g powder for injection vial

AUST R: 10327

Expected supply: 22 Jul 2022

Availability: Available

Updated: 22-07-2022



ciprofloxacin

DBL CIPROFLOXACIN 200 mg/100 mL injection for intravenous infusion bag

AUST R: 123041

Expected supply: 13 May 2022

Availability: Available

Updated: 07-06-2022


Tenecteplase

METALYSE tenecteplase (rch) 50mg powder for injection vial plus prefilled syringe

AUST R: 75013

Expected supply: 31 Mar 2023

Availability: Limited Availability

Management action: A TGA web statement is available at https://www.tga.gov.au/alert/shortage-tenecteplase-metalyse. The TGA has approved a shelf-life extension of certain batches of Metalyse by 12 months, information on batch numbers and extended expiry dates is available in the web statement.
Unregistered alternative products have been approved for supply under Section 19A. For information on supply, contact the approval holder, Pro Pharmaceuticals Group Pty Ltd on 1300 077 674.

Updated: 13-07-2022


heparin sodium

DBL HEPARIN SODIUM (porcine mucous) 5000IU/0.2mL injection BP ampoule

AUST R: 16349

Expected supply: 09 May 2022

Availability: Available

Updated: 11-05-2022


calcium folinate

Pfizer (Australia) LEUCOVORIN CALCIUM folinic acid (as calcium folinate) 50mg/5mL injection USP ampoule

AUST R: 61885

Expected supply: 30 Aug 2022

Availability: Available

Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.

Updated: 11-07-2022


chlorpromazine hydrochloride

LARGACTIL chlorpromazine hydrochloride 100mg tablet blister pack

AUST R: 51619

Expected supply: 11 May 2022

Availability: Available

Updated: 11-05-2022


benzylpenicillin sodium

BENPEN benzylpenicillin (as sodium) 1.2g powder for injection vial

AUST R: 10326

Expected supply: 15 Aug 2022

Availability: Unavailable

Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.

Updated: 20-07-2022


daunorubicin

Pfizer (Australia) DAUNORUBICIN (as hydrochloride) 20mg/10mL injection vial

AUST R: 12723

Expected supply: 30 Jun 2022

Availability: Available

Updated: 04-07-2022




ethosuximide

ZARONTIN ethosuximide 250mg capsule bottle

AUST R: 94175

Expected supply: 15 Jan 2023

Availability: Available

Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.

Updated: 05-08-2022


amiodarone hydrochloride

CORDARONE X INTRAVENOUS amiodarone hydrochloride 150mg/3mL injection ampoule

AUST R: 15360

Expected supply: 11 May 2022

Availability: Available

Updated: 11-05-2022


acetylcysteine

DBL ACETYLCYSTEINE injection concentrate acetylcysteine 2 g/ 10 mL injection ampoule

AUST R: 121503

Expected supply: 12 Aug 2022

Availability: Emergency Supply Only

Management action: Alternative generic product is available. An unregistered product has been approved for supply under Section 19A. Please contact the approval holder for details on supply: Orspec Pharma - Phone (02) 43394239 Email: sas@orspecpharma.com

Updated: 05-08-2022


adrenaline (epinephrine) acid tartrate

ADRENALINE-LINK 1:10,000 1mg/10mL adrenaline (epinephrine) acid tartrate injection BP ampoule

AUST R: 119194

Expected supply: 31 Jan 2023

Availability: Limited Availability

Management action: The sponsor is closely controlling the supply.

Updated: 16-06-2022


desferrioxamine mesilate

DBL DESFERRIOXAMINE MESYLATE FOR INJECTION BP 500mg powder for injection vial

AUST R: 53942

Expected supply: 25 Jul 2022

Availability: Available

Updated: 26-07-2022


amikacin

DBL AMIKACIN 500mg/2mL (as sulfate) injection vial

AUST R: 49945

Expected supply: 04 Nov 2022

Availability: Unavailable

Management action: Alternative generic products are available.

Updated: 16-06-2022


ioversol

OPTIRAY 320 Ioversol 33.9g/50mL injection vial

AUST R: 49422

Expected supply: 31 Dec 2022

Availability: Unavailable

Management action: A TGA webstatement is available at https://www.tga.gov.au/alert/shortage-iodinated-contrast-media-contrast-diagnostic-agents.
Unregistered products have been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient or 'contrast'.

Updated: 15-06-2022


ioversol

OPTIRAY 350 Ioversol 74% w/v 37.05g/50mL injection vial

AUST R: 47996

Expected supply: 31 Dec 2022

Availability: Unavailable

Management action: A TGA web statement is available at https://www.tga.gov.au/alert/shortage-iodinated-contrast-media-contrast-diagnostic-agents.
 
An unregistered product has been approved for supply under Section 19A. The approval holder, Guerbet Australia Pty Ltd can be contacted on 02 8075 3007 for details on supply.

Updated: 09-06-2022


ioversol

OPTIRAY 350 Ioversol 74% w/v 55.575g/75mL injection vial

AUST R: 47997

Expected supply: 31 Dec 2022

Availability: Unavailable

Management action: A TGA web statement is available at https://www.tga.gov.au/alert/shortage-iodinated-contrast-media-contrast-diagnostic-agents.
 
An unregistered product has been approved for supply under Section 19A. The approval holder, Guerbet Australia Pty Ltd can be contacted on 02 8075 3007 for details on supply.

Updated: 09-06-2022


ioversol

OPTIRAY 350 Ioversol 74% w/v 74.1g/100mL injection vial

AUST R: 47998

Expected supply: 31 Dec 2022

Availability: Unavailable

Management action: A TGA web statement is available at https://www.tga.gov.au/alert/shortage-iodinated-contrast-media-contrast-diagnostic-agents.
 
An unregistered product has been approved for supply under Section 19A. The approval holder, Guerbet Australia Pty Ltd can be contacted on 02 8075 3007 for details on supply.

Updated: 09-06-2022


naloxone hydrochloride dihydrate

NYXOID naloxone hydrochloride dihydrate 2.2 mg/actuation nasal spray vial

AUST R: 309381

Expected supply: 15 Nov 2022

Availability: Emergency Supply Only

Management action: Sponsor is closely monitoring supply.

An unregistered product has been approved for supply under Section 19A. The approval holder, Mundipharma Pty Ltd can be contacted on 1800 188 009 for details on supply.

Updated: 05-08-2022


vancomycin

DBL VANCOMYCIN vancomycin (as hydrochloride) 500mg powder for injection vial

AUST R: 62603

Expected supply: 31 Dec 2023

Availability: Unavailable

Management action: An alternative brand is available.

Updated: 15-06-2022


Ipilimumab

YERVOY ipilimumab (rch) 200mg in 40mL (5mg/mL) concentrate solution for IV infusion vial

AUST R: 174322

Expected supply: 09 Jun 2022

Availability: Available

Updated: 10-06-2022


warfarin sodium

MAREVAN warfarin sodium 1mg tablet bottle

AUST R: 12511

Expected supply: 12 Aug 2022

Availability: Limited Availability

Management action: The sponsor is closely controlling the supply.

Updated: 27-07-2022



mivacurium chloride

MIVACRON mivacurium 10mg/5mL (as chloride) injection ampoule

AUST R: 42972

Expected supply: 15 Aug 2022

Availability: Unavailable

Management action: The sponsor is working to expedite the next shipment.

Updated: 11-07-2022


calcium folinate hydrate

DBL LEUCOVORIN CALCIUM folinic acid 15 mg/2mL (as calcium folinate) injection ampoule

AUST R: 16351

Expected supply: Unknown

Availability: Reduction in supply until supply is exhausted

Management action: Alternate strengths available

Updated: 08-06-2022


idarubicin hydrochloride

ZAVEDOS idarubicin hydrochloride 10mg/10mL injection vial

AUST R: 67398

Expected supply: 15 Oct 2022

Availability: Available

Management action: The sponsor is closely controlling the supply and working to expedite the next shipment.

Updated: 15-06-2022


phenytoin sodium

DBL PHENYTOIN INJECTION BP 250mg/5mL ampoule

AUST R: 46943

Expected supply: 03 Sep 2022

Availability: Limited Availability

Management action: The sponsor is working to expedite the next shipment. An alternative brand is also available.

Updated: 06-07-2022


Tenecteplase

METALYSE tenecteplase (rch) 40mg powder for injection vial plus prefilled syringe

AUST R: 75012

Expected supply: 31 Mar 2023

Availability: Limited Availability

Management action: A TGA web statement is available at https://www.tga.gov.au/alert/shortage-tenecteplase-metalyse. The TGA has approved a shelf-life extension of certain batches of Metalyse by 12 months, information on batch numbers and extended expiry dates is available in the web statement.

Updated: 13-07-2022


voriconazole

VORICONAZOLE WOCKHARDT voriconazole 200 mg powder for injection vial

AUST R: 267013

Expected supply: 31 Dec 2022

Availability: Unavailable

Management action: Alternative generic products are available.

Updated: 11-07-2022


pimecrolimus

ELIDEL pimecrolimus 1% w/w cream tube

AUST R: 93680

Expected supply: 01 Aug 2022

Availability: Available

Updated: 01-08-2022


Updated: 22-07-2022


dexamethasone sodium phosphate

DEXAMETHASONE MYLAN dexamethasone phosphate (as dexamethasone sodium phosphate) 8mg/2mL solution for injection vial

AUST R: 163199

Expected supply: 31 Oct 2022

Availability: Limited Availability

Management action: An unregistered product has been approved for supply under Section 19A. The approval holder, Alphapharm Pty Ltd can be contacted on 1800 274 276 for details on supply

Updated: 12-07-2022


pyridostigmine bromide

MESTINON TIMESPAN pyridostigmine bromide 180mg tablet bottle

AUST R: 13749

Expected supply: 17 Oct 2022

Availability: Limited Availability

Management action: Sponsor is closely controlling the supply. An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.

Updated: 05-08-2022


morphine sulfate pentahydrate

DBL MORPHINE SULFATE 10mg/1mL injection BP ampoule

AUST R: 101240

Expected supply: 10 Aug 2022

Availability: Limited Availability

Management action: Alternative generic products are available.

Updated: 22-07-2022


Influenza virus haemagglutinin

FLUARIX TETRA inactivated split influenza vaccine suspension for injection 0.5 mL pre-filled PRTC syringe without needle

AUST R: 242512

Expected supply: 01 Apr 2023

Availability: Limited Availability

Management action: Seasonal depletion of stock.
An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.

Updated: 22-07-2022


pyridostigmine bromide

MESTINON pyridostigmine bromide 10mg tablet bottle

AUST R: 13747

Expected supply: 09 Sep 2022

Availability: Limited Availability

Management action: Supply of an alternative product is under consideration.

Updated: 26-07-2022


Enter an active ingredient or trade name

{{headingLabels[selectedTab]}}

Sort by: Updated date | Active ingredient | Trade name | Therapeutic class

{{atc}}

No {{headingLabels[status].toLowerCase()}} found.

  • View

URL: http://apps.tga.gov.au/prod/MSI/search/